O, M., S, R., J, A., F, G., J, T., JS, W., . . . Treluyer, J. (2007). CYP3A4/5 and pharmacogenetics in patients with sarcoma. Lancet Oncology, 8(8), 667. https://doi.org/10.1016/s1470-2045(07)70215-2
Chicago Style (17th ed.) CitationO, Mir, et al. "CYP3A4/5 and Pharmacogenetics in Patients with Sarcoma." Lancet Oncology 8, no. 8 (2007): 667. https://doi.org/10.1016/s1470-2045(07)70215-2.
MLA (9th ed.) CitationO, Mir, et al. "CYP3A4/5 and Pharmacogenetics in Patients with Sarcoma." Lancet Oncology, vol. 8, no. 8, 2007, p. 667, https://doi.org/10.1016/s1470-2045(07)70215-2.
Warning: These citations may not always be 100% accurate.